Health Economics and Outcomes Research (HEOR) and Real World Evidence (RWE) Solutions

Seamlessly integrated with domain expertise and analytical skills.

 

Pharmacoeconomic Modeling and Other Solutions

  • Health Economic Modeling
    • Cost-effectiveness and similar analyses
    • Budget impact models
    • Cost comparison models
  • Dynamic Disease Modeling
    • Epidemiological forecasting
    • Higher granular view of patient segments and lines of therapy
    • Used to provide inputs for commercial forecasts, and carry out scenario planning
  • Value Dossiers
    • Global dossiers and region/country-specific adaptations
    • Flexibility to assist with the whole of or parts of a value dossier
    • Leverage SmartAnalyt’s domain expertise from our strategic consulting business
  • Real World Data Analytics
    • Treatment patterns, switches, treatment sequences
    • Effectiveness and safety outcomes analysis
    • Unmet need and burden of illness (clinical, cost, health resource utilization)
    • Patient journey, physician specialty
    • Drug adherence/persistence, guidelines compliance
    • Advanced statistical analytics
  • Others
    • Risk-sharing assessment models
    • Publication support
    • Network Meta-Analyses and (Systematic) Literature Reviews

 

Real World Evidence and Patient Data Analytics

  • Outcomes Research
    • Treatment patterns (including adherence/persistence)
    • Treatment outcomes / survival analysis
    • Therapeutic landscape and real life drug uptake and utilization
    • Unmet need and burden of illness (clinical, cost, health resources)
    • Patient journey
  • Analytics/Biostatistics
    • Descriptive and comparative analytics
    • Propensity score and innovative matching techniques
    • Advanced statistical modelling
    • Survival models
    • Matching-adjusted indirect comparison
  • Epidemiology
    • Disease incidence / prevalence
    • Disease surveillance